Modulation of retinal Müller cells by complement receptor C5aR

Lijia Cheng1, Hong Bu, Jose-Andres C Portillo

  • 1Department of Pathology, Sichuan University, Chengdu, China.

Abstract

Insights

Complement receptor C5aR on Müller cells is upregulated by prostaglandin E2 and hyperglycemia. This signaling promotes retinal disease progression by increasing IL-6 and VEGF production, impacting endothelial cells in diabetic retinopathy.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Müller cells are key glial cells in the retina, implicated in diabetic retinopathy (DR).
  • Complement activation is linked to retinal diseases, but its role in Müller cell regulation is unknown.
  • Understanding Müller cell-complement interactions is crucial for retinal disease research.

Purpose of the Study:

  • To investigate the expression and function of complement receptor C5aR on human Müller cells.
  • To determine how prostaglandin E2 and hyperglycemia affect C5aR expression in Müller cells.
  • To elucidate the role of C5aR signaling in Müller cell-mediated retinal pathogenesis.

Main Methods:

  • Primary and immortalized human Müller cells were used to study C5aR expression (mRNA and protein).
  • The impact of prostaglandin E2 and hyperglycemia on C5aR regulation was assessed.
  • C5aR activation effects on cytokine production (IL-6, VEGF) and retinal endothelial cell behavior were examined.

Main Results:

  • Complement receptor C5aR is constitutively expressed in human Müller cells.
  • Prostaglandin E2 and hyperglycemia synergistically upregulate C5aR expression.
  • C5aR signaling stimulates IL-6 and VEGF release, promoting endothelial cell proliferation and permeability.

Conclusions:

  • Complement receptor C5aR plays a significant role in Müller cell function.
  • C5aR-mediated signaling in Müller cells contributes to the pathogenesis of retinal diseases like DR.
  • Targeting C5aR may offer therapeutic strategies for diabetic retinopathy.